• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Medline Industries buys Namic business from AngioDynamics

April 17, 2019 By Chris Newmarker

Medline AngioDynamicsMedline Industries will pay $167.5 million to acquire the Namic fluid management business from AngioDynamics (NSDQ:ANGO), the companies announced today.

The deal, subject to customary closing conditions, is expected to close in the summer. It will allow Medline to acquire the manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories offered under the Namic brand.

The Glens Falls, N.Y. plant and 330 workers serving the Namic brand will become part of Medline as part of the acquisition. The Glen Falls facility makes injection molded components and kits.

Medline officials plan to fold the Namic business into the company’s existing Cath Lab business to create a new division. The goal is enhanced market position and greater vertical integration, a company spokesman told Medical Design & Outsourcing.

“Medline’s scale and extensive kitting operations are sure to drive more momentum for Namic products and deliver opportunities for efficiency for customers,” Medline CEO Charlie Mills said in a news release.

AngioDynamics meanwhile plans to use the roughly $160 million in net cash proceeds from the deal to pay down its entire outstanding debt, as well as support strategic investments in the business.

“Over the past three years, we have streamlined our manufacturing operations and made significant improvements to our research and development process, enabling us to develop high-quality, innovative medical devices for our customers,” AngioDynamics CEO Jim Clemmer said in a news release. ,

“We are excited that this strategic transaction will enable us to accelerate highly-focused investments in our key therapeutic areas including oncology and thrombus management,” Clemmer added.

 

 

Filed Under: Catheters, Components, Injection Molding, Mold Components Tagged With: AngioDynamics, medline

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS